Canton Strategic Holdings (CNTN) Other Non Operating Income (2025 - 2026)
Canton Strategic Holdings (CNTN) reported Other Non Operating Income of $318178.0 for Q1 2026, up 6308.42% on a YoY basis from $4965.0 in Q1 2025, and up 6308.42% quarter-over-quarter from $4965.0 in Q1 2025.
Canton Strategic Holdings (CNTN) Other Non Operating Income (2025 - 2026) Analysis & Trends
Canton Strategic Holdings has reported Other Non Operating Income for 2 years, with the latest figure at $318178.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Canton Strategic Holdings | 699.97 Mn | 658.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 318,178.00 |
| Mar 31, 2025 | 4,965.00 |